Again, Oxaliplatin Is Toxic and No Benefit in Rectal CancerAgain, Oxaliplatin Is Toxic and No Benefit in Rectal Cancer

Yet another rectal cancer study has found that the addition of oxaliplatin to capecitabine chemoradiation in locally advanced disease gives no short-term postoperative benefit and increases toxicity. Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news